Effective Medical Treatment of Opiate Addiction

BIBLIOGRAPHY

• Institute of Medicine. Managing managed care: quality improvement in behavioral health. National Academy Press;, Washington 1997
   Google Scholar
• National evaluations of drug abuse treatment outcomes. Psych Addict Behav [Special Issue], press
   Google Scholar
• Anglin M D, Speckart G R, Booth M W, Ryan T M. Consequences and costs of shutting off methadone. Addict Behav 1989; 14: 307–26
   PubMed Web of Science ®Google Scholar
• Anglin M D, Hser Y. Treatment of drug abuse. Drugs and crime, M Tonry, J Q Wilson. University of Chicago Press;, Chicago 1990; 393–458
   Google Scholar
• Ball J C, Ross A. The effectiveness of methadone maintenance treatment. Springer Verlag;, New York 1991
   Google Scholar
• Barrett D H, Luk A J, Parrish R G, Jones T S. An investigation of medical examiner cases in which methadone was detected, Harris County, Texas, 1987–1992. J Forensic Sci May, 1996; 41(3)442–8
   PubMedGoogle Scholar
• Cadoret R J, Troughton E, O'Gorman T W, Heywood E. An adoption study of genetic and environmental factors in drug abuse. Arch Gen Psychiatry 1986; 43: 1131–6
   PubMed Web of Science ®Google Scholar
• Capelhorn J R, Hartel D M, Irwig L. Measuring and comparing the attitudes and beliefs of staff working in New York methadone maintenance clinics. Subst Use Misuse 1997; 32(4)399–413, 1
   PubMed Web of Science ®Google Scholar
• Caplehorn J R, Dalton M S, Haldar F, Petrenas A M, Nisbet J G. Methadone maintenance and addicts' risk of fatal heroin overdose. Subst Use Misuse Jan, 1996; 31(2)177–96
   PubMed Web of Science ®Google Scholar
• Cooper J R. Methadone treatment and acquired immunodeficiency syndrome. JAMA 1989; 252: 1664–8
   Google Scholar
• Cooper J R. Establishing a methadone quality assurance system: rationale and objectives. Improving drug abuse treatment. National Institute on Drug Abuse Research Monograph Series #106. DHHS, Washington 1991; 358–64
   Google Scholar
• Cooper J R. Including narcotic addiction treatment in an office-based practice. JAMA 1995a; 273: 1619–20
   PubMed Web of Science ®Google Scholar
• Courtwright D T. A century of American narcotic policy. Treating drug problems, D R Gerstein, H J Harwood. Institute of Medicine, National Academy Press;, Washington 1992; 2
   Google Scholar
• Des Jarlais D C. Research design, drug use, and deaths: cross study comparisons. The social and medical aspects of drug abuse, G Serban. Spectrum Publications, Jamaica (NY) 1984; 229–35
   Google Scholar
• Dole V P. Implications of methadone maintenance for theories of narcotic addiction. JAMA 1988; 260(20)3025–9
   PubMed Web of Science ®Google Scholar
• Dole V P. On federal regulation of methadone treatment. Conn Med 1996; 60: 428–9
   Google Scholar
• Dole V P. Hazards of process regulations: the example of methadone maintenance. JAMA 1992; 267: 2234–5
   PubMed Web of Science ®Google Scholar
• Edwards G, Gross M M. Alcohol dependence: previsional description of a clinical syndrome. Br Med 1996; 1: 1058–61
   Google Scholar
• Elk R, Grabowski J, Rhoades H M, McLellan A T. A substance abuse research-treatment clinic. Substance Abuse Treatment. 1993; 10(5)459–71
   PubMedGoogle Scholar
• Etheridge R M, Craddock S G, Dunteman G H, Hubbard R L. Treatment services in two national studies of community-based drug abuse treatment programs. J Subst Abuse Treat 1995; 7: 9–26
   Google Scholar
• Substance related disorders. Diagnostic and statistical manual of mental disorders. Fourth Edition. (DSM-IV), A Frances, H A Pincus, M B First. American Psychiatric Association Press, Washington 1994; 175–272
   Google Scholar
• Treating drug problems, D R Gerstein, H J Harwood. National Academy Press;, Institute of Medicine. Washington 1990; 1
   Google Scholar
• Goldstein A. Heroin addiction: neurobiology, pharmacology, and policy. J Psychoactive Drugs Apr, 1991; 23(2)123–33
   PubMed Web of Science ®Google Scholar
• Gossop M, Griffiths P, Bradley B, Strang J. Opiate withdrawal symptoms in response to 10-day and 21-day methadone withdrawal programmes. Br J Psychiatry 1989; 154: 360–3
   PubMed Web of Science ®Google Scholar
• Gronbladh L, Ohlund L S, Gunne L M. Mortality in heroin addiction: impact of methadone treatment. Acta Psychiatr Scand Sep, 1990; 82(3)223–7
   PubMed Web of Science ®Google Scholar
• Grudzinskas C V, Woosley R L, Payte J T, Collins J, Moody D E, Tyndale R F, et al. The documented role of pharmacogenetics in the identification and administration of new medications for treatment drug abuse. Problems of drug dependence 1995: Proceedings of the 57th Annual Scientific Meeting. NIDA research monograph. 1995; 60–3
   Google Scholar
• Hser Y, Anglin M D, Powers K. A 24-year follow-up of California narcotics addicts. Arch Gen Psychiatry 1993; 50: 577–84
   PubMed Web of Science ®Google Scholar
• Hser Y, Anglin M D, Grell C, Longshore D, Prendergast M. Drug treatment careers: a conceptual framework and existing research findings. J Subst Abuse 1997; 14(3)1–16
   Google Scholar
• Hser Y, Yamaguchi K, Anglin M D, Chen J. Effects of interventions on relapse to narcotics addiction. Eval Rev 1995; 19: 123–40
   Web of Science ®Google Scholar
• Hubbard R L, Marsden M E, Rachal J V, Harwood H J, Cavanaugh E R, Ginzburg H M. Drug abuse treatment: a national study of effectiveness. The University of North Carolina Press;, Chapel Hill 1995
   Google Scholar
• Hubbard R L, Craddock S G, Flynn P M, Anderson J, Etheridge R M. Overview of one-year follow up outcomes in DATOS. Psychology of Addictive Behaviors 1997; 11(4)
   Google Scholar
• Joe G W, Simpson D D, Sells S B. Treatment process and relapse to opioid use during methadone maintenance. Am J Drug Alcohol Abuse 1994; 20(2)173–97
   PubMed Web of Science ®Google Scholar
• Kleber H D. Outpatient detoxification from opiates. Primary Psychiatry 1996; 1: 42–52
   Google Scholar
• Kosten T R, Morgan C, Kleber H D. Treatment of heroin addicts using buprenorphine. Am J Drug Alcohol Abuse 1991; 7(1)119–28
   Google Scholar
• Krystal J H, Woods S W, Kosten T R, Rosen M I, Seibyl J P. Opiate dependence and withdrawal: preliminary assessment using single photon emission computerized tomography (SPECT). Am J Drug Alcohol Abuse Feb, 1995; 21(1)47–63
   PubMed Web of Science ®Google Scholar
• The medical prescription of narcotics, D Lewis, C Gear, M Laubli Loud, D Langenick-Cartwright, M Rihs-Middel. Hogrefe & Huber Publishers;, Toronto 1997
   Google Scholar
• Loimer N, Schmid R, Grünberger J, Jagsch R, Linzmayer L, Presslich O. Psychophysiological reactions in methadone maintenance patients do not correlate with methadone plasma levels. Psychopharmacology 1991; 103: 538–40
   PubMedGoogle Scholar
• London E D, Broussolle E P, Links J M, Wong D F, Cascella N G, Dannals R F, et al. Morphine-induced metabolic changes in human brain. Studies with positron emission tomography and [fluorine 18]fluorodeoxyglucose. Arch Gen Psychiatry Jan, 1990; 47(1)73–81
   PubMedGoogle Scholar
• McLellan A T, Woody G E, Luborsky L, O'Brien C P. Is the counselor an “active ingredient” in substance abuse treatment?. J Nerv Ment Dis 1988; 176(7)423–30
   PubMed Web of Science ®Google Scholar
• McLellan A T, Arndt I O, Alterman A I, Woody G E, Metzger D. Psychosocial services in substance abuse treatment: a dose-ranging study of psychosocial services. JAMA 1993
   Google Scholar
• McLellan A T, Alterman A I, Metzger D S, Grissom G, Woody G E, Luborsky L, et al. Similarity of outcome predictors across opiate, cocaine and alcohol treatments: role of treatment services. J Consult Clin Psychol 1994; 62: 1141–58
   PubMed Web of Science ®Google Scholar
• Mechanic D, Schlesinger M, McAlpine D D. Management of mental health and substance abuse services: state of the art and early results. Milbank Q 1995; 73: 19–55
   PubMed Web of Science ®Google Scholar
• Merikangas K R, Rounsaville B J, Prusoff B A. Familial factors in vulnerability to substance abuse. Vulnerability to drug abuse, M Glantz, R Pickens. American Psychological Association;, Washington 1992; 75–97
   Google Scholar
• Molinari S P, Cooper J R, Czechowicz D J. Federal regulation of clinical practice in narcotic addiction treatment: purpose, status, and alternatives. J Law Med Ethics 1994; 22(3)231–9
   PubMed Web of Science ®Google Scholar
• Murphy S, Irwin J. “Living with the dirty secret”: Problems of disclosure for methadone maintenance clients. J Psychoactive Drugs 1992; 24(3)257–64
   PubMed Web of Science ®Google Scholar
• Musto D F. The American disease Origins of narcotic control. Expanded edition. Oxford University Press;, New York 1987
   Google Scholar
• Nestler E J. Under siege: the brain on opiates. Neuron 1996; 16: 897–900
   PubMed Web of Science ®Google Scholar
• Novick M, Joseph H, Salsitz E A, Kalin M F, Keefe J B, Miller E L, et al. Outcomes of treatment of socially rehabilitated methadone maintenance patients in physicians' offices (medical maintenance): follow-up at three and a half to nine and a fourth years. J Gen Intern Med 1994; 9: 127–30
   PubMed Web of Science ®Google Scholar
• Nurco D N, Hanlon T E, Balter M B, Kinlock T W, Slaght E. A classification of narcotic addicts based on type, amount, and severity of crime. J Drug Issues 1991; 21: 429–48
   Web of Science ®Google Scholar
• Nurco D N, Cisin I H, Balter M B. Addicts career II: the first ten years. Addict 1981; 8: 1327–56
   Google Scholar
• Nurco D N, Ball J C, Shaffer J W, Hanlon T E. The criminality of narcotic addicts. J Nerv Ment Dis 1985; 173: 94–102
   PubMed Web of Science ®Google Scholar
• Nurco D N, Shaffer J W, Ball J C, Kinlock T W. Trends in the commission of crime among narcotic addicts over successive periods of addiction and nonaddiction. Am J Drug Alcohol Abuse 1984; 10: 481–9
   PubMed Web of Science ®Google Scholar
• Pickens R W, Svikis D S, McGue M, Lykken D T, Heston L L, Clayton P J. Heterogeneity in the inheritance of alcoholism. A study of male and female twins. Arch Gen Psychiatry 1991; 48: 19–28
   PubMed Web of Science ®Google Scholar
• Federal regulation of methadone treatment, R A Rettig, A Yarmolinsky. National Academy Press;, Institute of Medicine. Washington 1995
   Google Scholar
• Rhoades H, Creson D, Elk R, Schmitz J, Grabowski J. Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency. Am J Public Health 1997; 88: 34–9
   Google Scholar
• Rogowski J A. Insurance coverage for drug abuse. Health Aff 1992; 11(3)137–48
   Web of Science ®Google Scholar
• Scott J E, Greenberg D, Pizzaro J. A survey of state insurance mandates covering alcohol and other drug treatment. J Ment Health Adm 1992; 19(1)96–118
   PubMedGoogle Scholar
• Senay E C, Barthwell A G, Marks R, Boros P, Gillman D, White G. Medical maintenance: a pilot study. J Addict Dis 1993; 12(4)59–76
   PubMedGoogle Scholar
• Simpson D D. Effectiveness of drug-abuse treatment: a review of research from field settings. Treating drug abusers effectively, J A Egertson, D M Fox, A I Leshner. Blackwell Publishers of North America;, Cambridge, MA 1997; 42–73
   Google Scholar
• Simpson D D, Joe G W, Dansereau D F, Chatham L R. Strategies for improving methadone treatment process and outcomes. J Drug Issues 1997; 27(2)239–60
   Web of Science ®Google Scholar
• Tennant F S, Rawson R A, Cohen A, Tarver A, Clabout C. Methadone plasma levels and persistent drug abuse in high dose maintenance patients. Subst Alcohol Actions Misuse 1983; 4: 369–74
   PubMedGoogle Scholar
• Tsuang M T, Lyons M J, Eisen S A, Goldberg J, True W, Lin N, et al. Genetic influences on DSM-III-R drug abuse and dependence: a study of 3,372 twin pairs. Am J Med Genet 1996; 67: 473–7
   PubMed Web of Science ®Google Scholar
• Vining E, Kosten T R, Kleber H D. Clinical utility of rapid clonidine-naltrexone detoxification for opioid abuse. Br J Addict 1988; 83: 567–75
   PubMedGoogle Scholar
• Walsh S L, Gilson S F, Jasinski D R, Stapleton J M, Phillips R L, Dannals R F, et al. Buprenorphine reduces cerebral glucose metabolism in polydrug abusers. Neuropsychopharmacology May, 1994; 10(3)157–70
   PubMedGoogle Scholar
• Yancovitz S R, Des Jarlais D C, Peyser N P, Drew E, Friedmann P, Trigg H L, et al. A randomized trial of an interim methadone maintenance clinic. Am J Public Health 1991; 81(9)1185–91
   PubMed Web of Science ®Google Scholar
• Zweben J E, Payte J T. Methadone maintenance in the treatment of opioid dependence: a current perspective. West J Med 1990; 152(5)588–99
   PubMedGoogle Scholar